Prescription Price Regulations

The Department of Health and Human Services recently proposed a new regulation that addresses the price of prescription drugs. This new rule aims to lower drug prices by providing direct discounts to patients and repairing the broken rebate system. The current rebate system rewards increasing list prices, favors the middleman, and leaves patients without access to affordable drugs. This proposal promotes access for patients and strives to put them first.

WWFH partners throughout the country are invested in this issue and are advocating for transparency in the prescription drug distribution process. As the Administration takes the necessary steps forward, we urge you to join us in support of this initiative.

Click the links below to view a fact sheet on the proposed rule, to read the full proposal, and to browse articles surrounding the new regulation.

https://files.constantcontact.com/7886a309701/85777e1d-5a9b-4fc1-983a-a80b037d53f3.pdf

https://www.federalregister.gov/documents/2019/02/06/2019-01026/fraud-and-abuse-removal-of-safe-harbor-protection-for-rebates-involving-prescription-pharmaceuticals

https://www.forbes.com/sites/dougschoen/2019/02/05/we-must-reduce-drug-prices-with-policies-that-work-not-more-regulation/#22d6091561a9

https://m.washingtontimes.com/news/2019/feb/4/the-illusion-and-cost-of-drug-rebates/

http://drugwonks.com/blog/safeharbors-invisible-hands